Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/1995
03/23/1995WO1995007716A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
03/23/1995WO1995007715A1 Cd8+ cell antiviral factor
03/23/1995WO1995007706A1 The semaphorin gene family
03/23/1995WO1995005474A3 Glucoamylase promoter obtained from neurospora crassa and its use in the production of heterologous polypeptides
03/23/1995WO1995005393A3 Lipopolysaccharide-binding and neutralizing peptides
03/23/1995WO1995003333A3 Tryptase inhibitor
03/23/1995CA2171955A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
03/23/1995CA2171869A1 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor
03/23/1995CA2171739A1 Human mu opioid receptor
03/23/1995CA2170405A1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family
03/23/1995CA2170030A1 Pharmaceutical compositions containing ecotin and homologs thereof
03/22/1995EP0644201A1 Derivatives of gpl60 and vaccines based on gpl60 or a derivative thereof, containing an adjuvant
03/22/1995EP0643974A1 Vaccine against lyme disease
03/22/1995EP0643922A1 Flavouring agent
03/22/1995EP0643835A1 Htlv-i/htlv-ii assay and method
03/22/1995EP0643771A1 Cloning of the zymocin gene and use of zymocin in beverages
03/22/1995EP0643769A1 RECOMBINANT TIMOTHY GRASS POLLEN ALLERGEN $i(Phl p) II
03/22/1995EP0643767A1 Osteogenic peptides
03/22/1995EP0643728A1 Icam-related protein
03/22/1995EP0643719A1 Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor
03/22/1995EP0643586A1 Compositions useful in diagnosis and prophylaxis of lyme disease
03/22/1995EP0643559A1 Diphtheria toxin receptor-binding region
03/22/1995EP0504318B1 Recovery of bt endotoxin protein from lysed cell mixtures
03/22/1995EP0449958B1 Meningococcal class 1 outer-membrane protein vaccine
03/22/1995EP0299050B1 Isolation of single chain proteins with fsh suppressing activity from follicular fluid
03/22/1995EP0228452B1 Protein purification
03/22/1995CN1100272A Composition and process for enhancing the pre-adult growth and feed conversion efficiency of a porcine animal
03/21/1995US5399684 DNA sequences expressing mammalian alpha-1-antitrypsin
03/21/1995US5399680 Rice chitinase promoter
03/21/1995US5399677 Recombinant DNA molecules encoding mutant forms of the proteins; purified bone morphogenetic protein heterodimers
03/21/1995US5399574 5-hydroxytryptamine agonists; vasoconstrictors
03/21/1995US5399485 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis caused by Rochalimaea henselae
03/21/1995US5399283 Asparagine in polypeptide sequence is replaced; detergents
03/16/1995WO1995007467A1 Assay systems using the cntf signal transduction pathway
03/16/1995WO1995007466A2 Biotin-analog conjugated antibodies for positive cell selection and release
03/16/1995WO1995007463A1 Uses of green fluorescent protein
03/16/1995WO1995007462A1 Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases
03/16/1995WO1995007356A1 Method for the recombinant preparation of proteins in hansenula yeast
03/16/1995WO1995007354A1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
03/16/1995WO1995007353A2 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
03/16/1995WO1995007348A1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
03/16/1995WO1995007301A1 Recombinant il4 antibodies useful in treatment of il4 mediated disorders
03/16/1995WO1995007292A1 Antibiotics 10381v, w, x, y, z1, z2, pre-b and t
03/16/1995WO1995004151A3 Vaccine compositions containing recombinant tetc-fusion proteins
03/16/1995WO1995003415A3 Epstein-barr virus dna sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests
03/16/1995WO1995003405A3 Enzymatic method for modification of recombinant polypeptides
03/16/1995WO1995003328A3 Melanoma-inhibiting protein
03/16/1995WO1995000643A3 Human cell adhesion protein aamp-1 and uses thereof
03/16/1995CA2171193A1 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
03/16/1995CA2171112A1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
03/16/1995CA2170623A1 Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases
03/16/1995CA2169567A1 The recombinant production of proteins in yeast
03/16/1995CA2169298A1 Uses of green fluorescent protein
03/16/1995CA2168561A1 Antibiotics 10381v, w, x, y, z1, z2, pre-b and t
03/16/1995CA2168205A1 Biotin-analog conjugated antibodies for positive cell selection and release
03/15/1995EP0643136A1 Bacterion of Streptococcus thermophilus
03/15/1995EP0643077A1 Monoclonal antibody against B70 molecule
03/15/1995EP0643076A1 Novel peptide having receptor activity and dna coding for said peptide
03/15/1995EP0643075A1 Novel peptide having elastase inhibitor activity and process for producing the same
03/15/1995EP0642584A1 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors
03/15/1995EP0642581A1 Clostridium perfringens vaccines
03/15/1995EP0642580A1 Hepatocyte growth factor variants
03/15/1995EP0642579A1 Improved methods for the preparation of endotoxin-binding proteins
03/15/1995EP0642577A1 Antibodies with specificity for multiple adhesion molecules
03/15/1995EP0642524A1 Systemin
03/15/1995EP0642356A1 Antibodies to p-selectin and their uses
03/15/1995EP0642355A1 Combined vaccines comprising hepatitis b surface antigen and other antigens
03/15/1995EP0642354A1 METHODS FOR DETECTING AND ISOLATING uPA-R AND INHIBITING THE BINDING OF uPA TO uPA-R
03/15/1995EP0642350A1 Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties
03/15/1995EP0642348A1 Antibiotic cryptdin peptides and methods of their use
03/15/1995EP0309565B1 Subtilisin analogs
03/14/1995US5397712 In a living person, imunoassay using cerebrospinal fluid and a monoclonal antibody from a hybridoma ATCC HB11079
03/14/1995US5397703 Method for generation of antibodies to cell surface molecules
03/14/1995US5397701 Azido-substituted fatty acid analog enzyme substrates
03/09/1995WO1995006748A1 Monoclonal antibody that induces apoptosis
03/09/1995WO1995006747A1 Monoclonal antibody that recognizes interstitial cell surface antigen
03/09/1995WO1995006744A2 Methods of suppressing immune response by gene therapy
03/09/1995WO1995006739A1 Multiple integrative vectors and yarrowia lipolytica transformants
03/09/1995WO1995006736A1 BACTERIOCINS FROM $i(STREPTOCOCCUS THERMOPHILUS)
03/09/1995WO1995006735A2 Nucleotide sequences for novel protein tyrosine phosphatases
03/09/1995WO1995006732A2 Bacterial exported proteins and acellular vaccines based thereon
03/09/1995WO1995006729A1 Differentially expressed leishmania genes and proteins
03/09/1995WO1995006728A2 T cell epitopes of ryegrass pollen allergen
03/09/1995WO1995006727A2 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease
03/09/1995WO1995006726A2 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis
03/09/1995WO1995006725A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen
03/09/1995WO1995006723A1 Method of marking eukaryotic cells by the use of a cell surface receptor as a marker
03/09/1995WO1995006718A2 Methods of suppressing autoimmune response
03/09/1995WO1995006717A2 Methods of suppressing graft rejection
03/09/1995WO1995006666A1 Anti-gp39 antibodies and uses therefor
03/09/1995WO1995006664A1 Dna encoding prostaglandin receptor ep2
03/09/1995WO1995006662A1 Neuron regulatory factor for promoting neuron survival
03/09/1995WO1995006661A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF
03/09/1995WO1995006481A1 Methods for inducing antigen-specific t cell tolerance
03/09/1995WO1995006480A1 Methods of prolonged suppression of humoral immunity
03/09/1995WO1995006415A1 Senescent cell-derived inhibitors of dna synthesis
03/09/1995WO1994029457A3 Process for producing fusion proteins comprising scfv fragments by a transformed mould
03/09/1995DE4419399C1 Process for the preparation of heterologous bispecific antibodies
03/09/1995CA2170901A1 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease
03/09/1995CA2170751A1 Neuron regulatory factor for promoting neuron survival
1 ... 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 ... 1125